Restricted Net Assets (Tables)

12 Months Ended

Jun. 30, 2024

Restricted Net Assets [Abstract]

Schedule of Condensed Balance Sheets

Condensed Balance Sheets

	As of June 30,
	2024			2023
Assets
Current assets:
Cash and cash equivalents	$	2,721		$	49,598
Other current assets		169,071			169,071
Total current assets		171,791			218,668
Long-term equity investment		114,953,290			139,569,715
Total long-term assets		114,953,290			139,569,715
Total assets	$	115,125,082		$	139,788,383
Liabilities and shareholders’ equity
Current liabilities:
Accounts payable	$	214,520		$	214,520
Amount due to related parties		4,520,449			4,445,449
Other payables and accrued expenses		10,290,932			9,760,556
Total current liabilities		15,025,901			14,420,526
Shareholders’ equity
Common stock, $.001 par value, 115,197,165 shares authorized, 14,793,538 and 13,380,914 shares issued and outstanding as of June 30, 2024 and June 30, 2023, respectively		14,794			13,381
Additional paid-in capital		244,825,844			242,090,576
Accumulated other comprehensive loss		(26,550,536	)		(26,950,493	)
Retained earnings		(118,190,922	)		(89,785,607	)
Total shareholders’ equity		100,099,180			125,367,857
Total liabilities and shareholders’ equity	$	115,125,082		$	139,788,383

Schedule of Condensed Statements of Operations

Condensed Statements of Operations

	Year ended June 30,
	2024			2023
Revenue	$	-		$	-
General and administrative expenses		3,854,944			3,173,034
Interest income		12			1,076
Equity investment in subsidiaries		(24,550,383	)		(10,110,028	)
Net loss	$	(28,405,3153	)	$	(13,281,985	)

Schedule of Condensed Statements of Cash Flows

Condensed Statements of Cash Flows

	Year Ended June 30,
	2024			2023
Net cash used in operating activities	$	(399,789	)	$	(17,100,265	)
Net cash (used in) provided by investing activities		(1,502,600	)		2,001,000
Net cash provided by financing activities		191,000			17,097,130
Cash and cash equivalents, beginning balance		2,050,350			52,484
Cash and cash equivalents, ending balance	$	338,961		$	2,050,350